Xiao-Tao Chen

This inventor holds 22 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Opioid Receptor Ligands. Top assignees: Trevena, Inc., Bristol-Myers Squibb Compnay, Bristol-Myers Squibb Pharma Company. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao-Tao Chen. Retrieved from https://idiyas.com/inventor/xiao-tao-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 3)

% Patents Active = 90.9

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 180(Granted Patents)

Location History:

New York, NY (US) (2001)
Newark, DE (US) (2003 - 2006)
Furlong, PA (US) (2007 - 2024)

Company Filing History:

Bristol-Myers Squibb Compnay

patents

1 out of 234

Bristol-Myers Squibb Pharma Company

Sloan-Kettering Institute for Cancer Research

Years Active: 2001-2024

Loading Chart...

Areas of Expertise:

Opioid Receptor Ligands

Beta-Arrestin Effectors

Kinase Inhibitors

Matrix Metalloproteinases

Glucocorticoid Receptor

Fused Heterocyclic Compounds

Synthetic Processes

Cyclic Hydroxamic Acids

1,3-Dihydro-Imidazol Derivatives

Met Kinase Inhibitors

Pyrrolotriazine Compounds

O-Linked Glycoconjugates

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11931350 - Opioid receptor ligands and methods of using and making same (2024-03-19),

2. 11077098 - Opioid receptor ligands and methods of using and making same (2021-08-03),

3. 10588898 - Opioid receptor ligands and methods of using and making same (2020-03-17),

4. 9849119 - Opioid receptor ligands and methods of using and making same (2017-12-26),

5. 9642842 - Opioid receptor ligands and methods of using and making same (2017-05-09),

6. 9534017 - Beta-arrestin effectors and compositions and methods of use thereof (2017-01-03),

7. 9309234 - Opioid receptor ligands and methods of using and making same (2016-04-12),

8. 9044469 - Opioid receptor ligands and methods of using and making same (2015-06-02),

9. 8993511 - β-arrestin effectors and compositions and methods of use thereof (2015-03-31),

10. 8835488 - Opioid receptor ligands and methods of using and making same (2014-09-16),

11. 8809260 - β-arrestin effectors and compositions and methods of use thereof (2014-08-19),

12. 8796204 - β-arrestin effectors and compositions and methods of use thereof (2014-08-05),

13. 8486885 - β-arrestin effectors and compositions and methods of use thereof (2013-07-16),

14. 7547782 - Met kinase inhibitors (2009-06-16),

15. 7439246 - Fused heterocyclic kinase inhibitors (2008-10-21),

Title: Innovator Spotlight: Xiao-Tao Chen - Revolutionizing Pain Treatment

Introduction:

Xiao-Tao Chen, a talented inventor based in Furlong, PA, is making significant strides in the field of pharmaceuticals with his groundbreaking patents and innovative research. With a total of 22 patents to his name, his work is reshaping the landscape of pain management and related disorders.

Latest Patents:

Among Xiao-Tao Chen's latest patents is the development of opioid receptor ligands and methods of using and making them. These compounds exhibit promising potential as effective opioid receptor ligands for treating pain and associated disorders. The research behind these patents showcases his dedication to advancing medical solutions for crucial health challenges.

Career Highlights:

Having contributed his expertise to renowned companies like Trevena, Inc. and Bristol-Myers Squibb Company, Xiao-Tao Chen has honed his skills and knowledge in the pharmaceutical industry. His experience and leadership have been instrumental in driving innovation and achieving breakthroughs in drug development.

Collaborations:

Throughout his career, Xiao-Tao Chen has collaborated closely with esteemed professionals in the field, including Dennis Shinji Yamashita and Dimitar B Gotchev. Together, they have pooled their talents and insights to push the boundaries of pharmaceutical research and create impactful solutions for healthcare.

Conclusion:

In conclusion, Xiao-Tao Chen's remarkable journey as an inventor underscores his invaluable contributions to the realm of pharmaceutical innovations. With a keen focus on enhancing pain treatment methodologies, he continues to inspire change and make a lasting impact on the healthcare industry. His relentless pursuit of excellence sets a high standard for future advancements in medicine and drug development.

Profile summary based on public USPTO records.